Regulatory Show all
July 23 | 2019

2cureX meddelar att patienter framgångsrikt inkluderats i pankreascancerstudie med IndiTreat®

Read more
June 25 | 2019

Byte av Certified Adviser till Svensk Kapitalmarknadsgranskning AB

Read more
June 25 | 2019

Change of Certified Adviser to Svensk Kapitalmarknadsgranskning AB

Read more
May 10 | 2019

2cureX inbjuder till investerarträff i Stockholm den 15 maj 2019

Read more
May 10 | 2019

2cureX invites to an investor meeting in Stockholm on May 15th, 2019

Read more
April 4 | 2019

2cureX offentliggör kommersiellt samarbete med Gibson Oncology, USA

Read more
April 4 | 2019

2cureX announces commercial collaboration with Gibson Oncology, USA

Read more
March 28 | 2019

2cureX receives Notice of Allowance from the United States Patent Office

Read more
March 28 | 2019

2cureX erhåller Notice of Allowance från det amerikanska patentverket

Read more
March 12 | 2019

2cureX utvidgar verksamheten till förebyggande cancermedicin

Read more
March 12 | 2019

2cureX expands its activities to preventive cancer medicine

Read more
February 20 | 2019

Correction – Lack of reference to MAR – 2cureX meddelar positiva resultat från pågående klinisk studie med kraftigt förbehandlade kolorektalcancerpatienter

Read more
February 20 | 2019

Correction – Lack of reference to MAR – 2cureX reports positive results from an ongoing clinical trial in heavily pre-treated colorectal cancer patients

Read more
February 20 | 2019

2cureX meddelar positiva resultat från pågående klinisk studie med kraftigt förbehandlade kolorektalcancerpatienter

Read more
February 20 | 2019

2cureX reports positive results from an ongoing clinical trial in heavily pre-treated colorectal cancer patients

Read more
February 1 | 2019

2cureX gathered decision makers at New Year’s Reception

Read more